Résultats de la recherche
10
Tout
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism
13 janv. 2025 08h30 HE
|
Inquis Medical
Inquis Medical Completes Enrollment in AVENTUS US Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism
Coagulation Market Worth $10.85 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
16 oct. 2023 08h13 HE
|
The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Coagulation or clotting is the process by which blood turns from a liquid into a gel and forms a blood clot. This potentially leads to hemostasis,...
Antiplatelet Drugs Market to Hit USD 4.1 Bn by 2031 Due to the Increase in Prevalence of Cardiovascular Diseases, Latest Study by TMR
20 mars 2023 17h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global antiplatelet drugs market size was valued USD 2.1 Bn in 2022 and it is...
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
07 déc. 2022 11h00 HE
|
Association of American Physicians and Surgeons (AAPS)
TUCSON, Ariz., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled...
Low Molecular Weight Heparin Market Size Worth $5,733.96 Mn, Globally, by 2028 at 6.6% CAGR - Exclusive Report by The Insight Partners
11 févr. 2022 06h26 HE
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin,...
Blood Clot Risk among People with Cancer
02 oct. 2019 09h35 HE
|
Stop the Clot, Spread the Word™
GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- The National Blood Clot Alliance (NBCA) and the Centers for Disease Control and Prevention (CDC) are rolling out a new suite of resources from...
AHA Perspective on FDA Committee Decision on Rivaroxaban
08 sept. 2011 18h26 HE
|
American Heart Association
DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...